Mirum Pharmaceuticals (MIRM) Enterprise Value (2020 - 2025)
Historic Enterprise Value for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to -$375.5 million.
- Mirum Pharmaceuticals' Enterprise Value fell 3202.83% to -$375.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$375.5 million, marking a year-over-year decrease of 3202.83%. This contributed to the annual value of -$280.3 million for FY2024, which is 209.94% up from last year.
- Per Mirum Pharmaceuticals' latest filing, its Enterprise Value stood at -$375.5 million for Q3 2025, which was down 3202.83% from -$304.6 million recorded in Q2 2025.
- Over the past 5 years, Mirum Pharmaceuticals' Enterprise Value peaked at -$132.1 million during Q1 2023, and registered a low of -$434.9 million during Q3 2022.
- Its 5-year average for Enterprise Value is -$297.5 million, with a median of -$294.7 million in 2022.
- As far as peak fluctuations go, Mirum Pharmaceuticals' Enterprise Value soared by 6040.22% in 2023, and later tumbled by 12929.97% in 2024.
- Quarter analysis of 5 years shows Mirum Pharmaceuticals' Enterprise Value stood at -$256.5 million in 2021, then rose by 1.88% to -$251.7 million in 2022, then decreased by 13.75% to -$286.3 million in 2023, then rose by 2.1% to -$280.3 million in 2024, then plummeted by 33.97% to -$375.5 million in 2025.
- Its last three reported values are -$375.5 million in Q3 2025, -$304.6 million for Q2 2025, and -$277.7 million during Q1 2025.